ICBMT 2024. ICBMT 2024. THE 8th INTERNATIONAL CONGRESS OF BMT 2024. THE 29th ANNUAL CONGRESS OF KSBMT.

Moving Forward into the New Era of HSCT and Cellular Therapy

SEPTEMBER 26(Thu) - 28(Sat), 2024. BEXCO, BUSAN, KOREA

Scientific Program

SELECT AND VIEW SESSIONS OF YOUR CHOICE
Search

Oral Presentation 1

Room A
(2F)
Date & Time Sep. 26 (Thu), 09:00-10:00
Chair(s) Min Kyoung Kim (Yeungnam University College of Medicine)
Ho Sup Lee (Kosin University College of Medicine)
Speaker(s) 09:00-09:10 Clinical Implication and Long-term Survival Outcome of Second Allogeneic HCT in Adult Patients with Relapsed Acute Lymphoblastic Leukemia before and after the Era of Novel Immunotherapeutic Agents Daehun Kwag (The Catholic University of Korea)
09:10-09:20 Optimization of Pre-Transplant Conditioning for Haploidentical Donor Transplantation in Adult Acute Lymphoblastic Leukemia: Interim Phase 2 Results of TBI-Augmented Reduced Toxicity Regimen Incorporating ATG/PTC Jaehyun Ahn (The Catholic University of Korea)
09:20-09:30 Selection of Candidates for Allogenic Hematopoietic Stem Cell Transplantation with T-Lymphoblastic lymphoma by Comparative Study with T-Acute Lymphoblastic Leukemia Tong Yoon Kim (The Catholic University of Korea)
09:30-09:40 Optimization of TBI-Based Myeloablative Conditioning Regimen Incorporating ATG and PTCY in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: Historical Comparison with TBI/CY Jongseo Lee (The Catholic University of Korea)

Oral Presentation 2

Room B
(2F)
Date & Time Sep. 26 (Thu), 09:00-10:00
Chair(s) Jae Hoon Lee (Gachon University College of Medicine)
Kihyun Kim (Sungkyunkwan University School of Medicine)
Speaker(s) 09:00-09:10 Impact of Tandem Autologous Stem Cell Transplantation in Multiple Myeloma Patients with MRD Positivity after First Transplantation, CARE-MM Study-2401 Sieun Oh (The Catholic University of Korea)
09:10-09:20 CD4 Cytotoxic T Cells Promote Antitumor Immunity in Multiple Myeloma Sojeong Kim (Yonsei University College of Medicine)
09:20-09:30 Discoidin Domain Receptor 1 (DDR1) is Associated with Treatment Outcomes in Multiple Myeloma (MM) after Autologous Stem Cell Transplantation Ji-Young Lim (The Catholic University of Korea)
09:30-09:40 Mezigdomide plus Tazemetostat and Dexamethasone for Relapsed or Refractory Multiple Myeloma: Preliminary Results from the CA057-003 Trial Paul Richardson (Dana-Farber Cancer Institute)
09:40-09:50 Evaluating the Efficacy and Safety of Immunotherapeutic T-Cell Engagers in Relapsed/Refractory Multiple Myeloma: A Real-World Comparison Data Analysis Mimicking RCT Sung-Soo Park (The Catholic University of Korea)
09:50-10:00 High B-cell Maturation Antigen Surface Expression on Myeloma Cells is Associated with Poor Survival Outcomes in Patients with Multiple Myeloma Suhyeon Hwang (Yonsei University College of Medicine)

Oral Presentation 3

Room C
(1F)
Date & Time Sep. 26 (Thu), 09:00-10:00
Chair(s) Inho Kim (Seoul National University College of Medicine)
Seong Hyun Jeong (Ajou University School of Medicine)
Speaker(s) 09:00-09:10 Early Prediction of Hypomethylating Agent Based Therapy Outcome in Elderly Myeloid Disease Patients: A Geriatric Functional Assessment Approach Mihee Kim (Chonnam National University Medical School)
09:10-09:20 Diagnostic NGS Panel-Based Serial Measurable Residual Disease Monitoring as a Prognostic Indicator in Acute Myeloid Leukemia Patients Jae-Sook Ahn (Chonnam National University Medical School)
09:20-09:30 Role of Allogeneic Stem Cell Transplantation in FLT3-ITD Mutated AML Patients Treated with Midostaurin: A Comparative Analysis with Standard Chemotherapy Kyoung Il Min (The Catholic University of Korea)
09:30-09:40 Transplantation Outcomes after Venetoclax-Decitabine Compared to Conventional Chemotherapy as an Induction Therapy: A Propensity Score Matched Cohort Analysis Ka Young Kim (The Catholic University of Korea)
09:40-09:50 Phase I Study to Evaluate Safety of VT-Tri after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) Ki-Hyun Park (ViGenCell)
09:50-10:00 Post-Transplant Outcomes in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Following Gilteritinib Treatment Daehun Kwag (The Catholic University of Korea)

Oral Presentation 4

Room D
(1F)
Date & Time Sep. 26 (Thu), 09:00-10:00
Chair(s) Hyo Jung Kim (Hallym University College of Medicine)
Yeon Jung Lim (Chungnam National University College of Medicine)
Speaker(s) 09:00-09:10 Risk Factors and Prognosis of Invasive Fungal Disease Following Hematopoietic Stem Cell Transplantation in 1076 Pediatric Patients Jiaming Yu (Shenzhen Children's Hospital)
09:10-09:20 Korean Real-World Data of Defibrotide for Treatment of Adult Patients who Developed Severe Hepatic VOD/SOS after Allogeneic Hematopoietic Cell Transplantation Jae Ho Yoon (The Catholic University of Korea)

Plenary Session 1

Sep. 26 (Thu), 10:40-12:00
Room A
(2F)
Chair(s) Ki Woong Sung (Sungkyunkwan University School of Medicine)
  • Waseem Qasim

    Expanding Horizons of CAR T-Cell Therapy through Genome Editing

    UCL Great Ormond Street Institute of Child Health, UK

  • Sang-Ki Kim

    Innovative Cellular Immunotherapy: Harnessing NK Cells, T Cells, and CAR-based Therapies for Cancer Treatment

    Department of Companion and Laboratory Animal Science, Kongju National University, Korea

Luncheon Symposium 1

Sep. 26 (Thu), 12:10-12:50
Room A
(2F)
Chair(s) Hyeon-Seok Eom (National Cancer Center)
  • Efstathios Kastritis

    Paving the Future of AL Amyloidosis Treatment with Daratumumab-based Treatment

    National and Kapodistrian University of Athens School of Medicine, Greece

Luncheon Symposium 2

Sep. 26 (Thu), 12:10-12:50
Room B
(2F)
Chair(s) Sang Kyun Sohn (Kyungpook National University School of Medicine)
  • Dennis Kim

    New Chapter of cGvHD Therapeutics: Belumosudil

    Princess Margaret Cancer Centre, Canada

Luncheon Symposium 3

Sep. 26 (Thu), 12:10-12:50
Room C
(1F)
Chair(s) Sung-Hyun Kim (Dong-A University College of Medicine)
  • Olaf Penack

    Invisible Invaders: All Things to Know about Fungal Infection in Hematology

    Charité - Universitätsmedizin Berlin, Germany

Luncheon Symposium 4

Sep. 26 (Thu), 12:10-12:50
Room D-1
(1F)
Chair(s) Jong Wook Lee (Hanyang University Medical Center)
  • Jun Ho Jang

    From Second-Line to First-line: The Evolving Role of Romiplostim in Severe Aplastic Anemia Management

    Sungkyunkwan University School of Medicine, Korea

Luncheon Symposium 5

Sep. 26 (Thu), 12:10-12:50
Room D-2
(1F)
Chair(s) Hee-Je Kim (The Catholic University of Korea)
  • Dong-Yeop Shin

    How I Manage of Unfit AML Patients with Venetoclax for Long-term Survival

    Seoul National University College of Medicine, Korea

Plenary Session 2

Sep. 26 (Thu), 13:00-14:20
Room A
(2F)
Chair(s) Jong Wook Lee (Hanyang University Medical Center)
  • Kate Markey

    Exploring the Influence of the Microbiome on Hematopoiesis and Immune Reconstitution

    Fred Hutchinson Cancer Center, USA

  • Donal McLornan

    Unraveling the Significance of Germline Predisposition Mutations in MDS prior to Transplantation

    University College London Hospitals NHS Foundation Trust, UK

Joint Symposium 1

Sep. 26 (Thu), 14:30-16:00
Room A
(2F)
Chair(s) Je-Jung Lee (Chonnam National University Medical School)
Stanley Riddell (Fred Hutchinson Cancer Center)
  • Jordan Gauthier

    Strategies to Mitigate CAR T-Cell-Associated Cytokine Release Syndrome and Neurologic Toxicity

    Fred Hutchinson Cancer Center, USA

  • Peter Riedell

    Real-World Outcomes with CAR T-Cell Therapy for Lymphoid Malignancies

    University of Chicago, USA

  • Seok Jin Kim

    Real-World Data of CAR-T in Refractory Lymphoma in Korea

    Sungkyunkwan University School of Medicine, Korea

Scientific Session 1

Sep. 26 (Thu), 14:30-16:00
Room B
(2F)
Chair(s) Sung-Soo Yoon (Seoul National University College of Medicine)
Myung Geun Shin (Chonnam National University Medical School)
  • Zachariah DeFilipp

    Role of Tissue Niches in Acute GI-GVHD Revealed by Spatial Transcriptomics

    Massachusetts General Hospital, USA

  • Paul G. Richardson

    Endotheliopathies after Transplant and Immune Therapies in Hematologic Malignancy, with a Focus on the Evolving Role of Defibrotide, Including Its Potential in the Endotheliitis of COVID-19

    Dana-Farber Cancer Institute, USA

  • Luca Vago

    "Leukemia Immune Escape in Posttransplantation Relapses: From Biology to Personalized Medicine (And Back) "

    IRCCS San Raffaele Scientific Institute, Italy

Scientific Session 2

Sep. 26 (Thu), 14:30-16:00
Room C
(1F)
Chair(s) Jong Ho Won (Soonchunhyang University College of Medicine)
Ho Joon Im (University of Ulsan College of Medicine)
  • Xiao-Jun Huang

    The Optimization for T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation

    Peking University People's Hospital, China

  • Takanori Teshima

    PBSCT Using Posttransplant Cyclophosphamide from HLA-Matched and 1-2 Allele Mismatched Donor

    Hokkaido University, Japan

  • Satoshi Takahashi

    Strategies to Enhance Graft Performance in Cord Blood Transplantation

    The University of Tokyo, Japan

Education Session 1

Sep. 26 (Thu), 14:30-16:00
Room D
(1F)
Chair(s) Ho-Jin Shin (Pusan National University School of Medicine)
Byung Sik Cho (The Catholic University of Korea)
  • Jamin Koo

    Assisting Treatment Selection Based on Big Data and Machine Learning

    Department of Chemical Engineering, Hongik University, Korea

  • Jeong-Moo Lee

    Strategies for Integrating ChatGPT and Generative AI into Clinical Studies

    Department of Surgery, Seoul National University College of Medicine, Korea

  • Hyery Kim

    Machine Learning Applications in Hematopoietic Cell Transplantation

    University of Ulsan College of Medicine, Korea

Nursing Session 1

Sep. 26 (Thu), 16:40-18:10
Room D
(1F)
Chair(s) Minjin Choi (Samsung Medical Center)
  • Hong Ghi Lee

    Chasing after Blood Cancer for Forty Years

    Konkuk University Medical Center, Korea

  • Eun Seok Choi

    "A 27-Year Journey as a Transplant Nurse ""Empathy, Passion, and Resilience"""

    Asan Medical Center, Korea

  • Yeon-Soo Seo

    A New Life Yet to Come: Twists and Turns in My Life as a Life Scientist and Cancer Patient

    Department of Biological Sciences, KAIST, Korea

Joint Symposium 2

Sep. 26 (Thu), 16:40-18:20
Room A
(2F)
Chair(s) Seong Kyu Park (Soonchunhyang University College of Medicine)
Takanori Teshima (Hokkaido University)
  • Kazuto Ogura

    Aging Landscape and Pre-Transplantation Considerations for Elderly Patients in Japan

    Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan

  • Yuki Taya

    Transplantation Strategies and Outcome of Elderly Patients with Acute Leukemia in Japan

    Toranomon Hospital, Japan

  • Dae Hun Kwag

    Geriatric Functional Assessments and Their Utility for Standard Intensive Chemotherapy and HSCT

    The Catholic University of Korea, Korea

  • Joon Ho Moon

    Transplantation Strategies and Outcome of Elderly Patients with Acute Leukemia in Korea

    Kyungpook National University School of Medicine, Korea

Scientific Session 3

Sep. 26 (Thu), 16:40-18:10
Room B
(2F)
Chair(s) Hoon Kook (Chonnam National University Medical School)
Deok Hwan Yang (Chonnam National University Medical School)
  • Jeremy Abramson

    Choosing a CAR for Relapsed/Refractory DLBCL: Which CAR, for Whom, and When

    Massachusetts General Hospital, Harvard Medical School, USA

  • Neil Berinstein

    Cellular Therapy for Primary and Secondary CNS Lymphoma: Transplantation? or CAR-T?

    Sunnybrook Health Sciences Centre, Canada

  • Hyoung Jin Kang

    Optimization of CAR-T Therapy for Acute Lymphoblastic Leukemia

    Seoul National University College of Medicine, Korea

Scientific Session 4

Sep. 26 (Thu), 16:40-18:10
Room C
(1F)
Chair(s) Nack-Gyun Chung (The Catholic University of Korea)
Seongsoo Jang (University of Ulsan College of Medicine)
  • Lisa J. McReynolds

    Interpretation of Germline Variants of IBMFS in Adult Patients with Hematologic Diseases

    National Cancer Institute, USA

  • Shinichi Kako

    Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy in Aplastic Anemia

    Jichi Medical University Saitama Medical Center, Japan

  • Boram Kim

    Genetic Diagnosis of Inherited Bone Marrow Failure Syndromes in the Era of Next-generation Sequencing

    Sungkyunkwan University School of Medicine, Korea